000			01392 a2200397 4500
005			20250511132315.0
264		0	_c19780321
008			197803s 0 0 eng d
022			_a0025-7125
024	7		_a10.1016/s0025-7125(16)31830-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aSachar, D B
245	0	0	_aImmunotherapy in inflammatory bowel disease. _h[electronic resource]
260			_bThe Medical clinics of North America _cJan 1978
300			_a173-83 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Review
650	0	4	_aAdult
650	0	4	_aAlkylating Agents _xtherapeutic use
650	0	4	_aAntimetabolites _xtherapeutic use
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aChild
650	0	4	_aClinical Trials as Topic
650	0	4	_aColitis, Ulcerative _xdrug therapy
650	0	4	_aCrohn Disease _xdrug therapy
650	0	4	_aCromolyn Sodium _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMercaptopurine _xtherapeutic use
650	0	4	_aMetronidazole _xtherapeutic use
700	1		_aPresent, D H
773	0		_tThe Medical clinics of North America _gvol. 62 _gno. 1 _gp. 173-83
856	4	0	_uhttps://doi.org/10.1016/s0025-7125(16)31830-2 _zAvailable from publisher's website
999			_c434588 _d434588